Literature DB >> 25486286

Necrotizing enterocolitis in infants with ductal-dependent congenital heart disease.

Kristian C Becker1, Christoph P Hornik1, C Michael Cotten2, Reese H Clark3, Kevin D Hill1, P Brian Smith1, Robert W Lenfestey1.   

Abstract

OBJECTIVE: Infants with congenital heart disease (CHD) receiving prostaglandins (PGEs) may be at an increased risk for necrotizing enterocolitis (NEC). Enteral feeding may further increase the risk of NEC in these patients. We evaluated the incidence of NEC and its association with enteral feeding in infants with ductal-dependent CHD. STUDY
DESIGN: We examined a cohort of infants with CHD receiving PGE in neonatal intensive care units managed by the Pediatrix Medical Group (Sunrise, FL) between 1997 and 2010. We used logistic regression to evaluate the association between NEC and enteral feeding, as well as other risk factors, including antacid medications, inotropic and ventilator support, and anatomic characteristics, controlling for gestational age.
RESULTS: We identified 6,710 infants with ductal-dependent CHD receiving PGE for 17,158 infant days. NEC occurred in 21 of the 6,710 (0.3%) infants, of whom 12/21 (57%) were < 37 weeks gestational age. The incidence of NEC was 1.2/1,000 infant days while on enteral feeds versus 0.4/1,000 infant days while not on enteral feeds (p = 0.27). Enteral feeding was not associated with a statistically significant increased odds of NEC on the day of diagnosis (odds ratio [OR] 2.08; 95% confidence interval [CI] 0.38, 11.7). Risk factors associated with a significant increased odds of NEC included a diagnosis of single-ventricle heart defect (OR 2.82; 95% CI 1.23, 6.49), although the overall risk in this population remained low (8/1,631, 0.5%).
CONCLUSION: The incidence of NEC in our cohort of infants with ductal-dependent CHD on PGE therapy was low and did not increase with enteral feeding. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25486286      PMCID: PMC4449801          DOI: 10.1055/s-0034-1390349

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   3.079


  27 in total

1.  Rapid advancement to more concentrated formula in infants after surgery for congenital heart disease reduces duration of hospital stay: a randomized clinical trial.

Authors:  Francy Pillo-Blocka; Ian Adatia; Waseem Sharieff; Brian W McCrindle; Stanley Zlotkin
Journal:  J Pediatr       Date:  2004-12       Impact factor: 4.406

2.  Persistent diastolic flow reversal in abdominal aortic Doppler-flow profiles is associated with an increased risk of necrotizing enterocolitis in term infants with congenital heart disease.

Authors:  Waldemar F Carlo; Thomas R Kimball; Erik C Michelfelder; William L Border
Journal:  Pediatrics       Date:  2007-02       Impact factor: 7.124

3.  Necrotizing enterocolitis in a term infant with coarctation of the aorta complex.

Authors:  T Hasegawa; Y Yoshioka; T Sasaki; Y Iwasaki; Y Miki; J Sumimura; H Koyama; T Dezawa
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

Review 4.  Necrotising enterocolitis.

Authors:  Patricia W Lin; Barbara J Stoll
Journal:  Lancet       Date:  2006-10-07       Impact factor: 79.321

5.  Aldohexose malabsorption in preterm pigs is directly related to the severity of necrotizing enterocolitis.

Authors:  Randal K Buddington; Stine B Bering; Thomas Thymann; Per T Sangild
Journal:  Pediatr Res       Date:  2008-04       Impact factor: 3.756

6.  Short- and long-term outcomes of necrotizing enterocolitis in infants with congenital heart disease.

Authors:  Sarah S Pickard; Jeffrey A Feinstein; Rita A Popat; Lyen Huang; Sanjeev Dutta
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

7.  Mesenteric oxygen desaturation in an infant with congenital heart disease and necrotizing enterocolitis.

Authors:  Gary E Stapleton; Brian K Eble; Heather A Dickerson; Dean B Andropoulos; Anthony C Chang
Journal:  Tex Heart Inst J       Date:  2007

Review 8.  Molecular signaling in necrotizing enterocolitis: regulation of intestinal COX-2 expression.

Authors:  Brian Lugo; Henri R Ford; Anatoly Grishin
Journal:  J Pediatr Surg       Date:  2007-07       Impact factor: 2.545

9.  Enteral feeding in prostaglandin-dependent neonates: is it a safe practice?

Authors:  Lisa Willis; Patti Thureen; Jonathan Kaufman; Erica Wymore; Heather Skillman; Eduardo da Cruz
Journal:  J Pediatr       Date:  2008-12       Impact factor: 4.406

Review 10.  Necrotizing enterocolitis in neonates with congenital heart disease.

Authors:  Peter J Giannone; Wendy A Luce; Craig A Nankervis; Timothy M Hoffman; Loren E Wold
Journal:  Life Sci       Date:  2008-01-09       Impact factor: 5.037

View more
  12 in total

1.  Human Milk Use in the Preoperative Period Is Associated with a Lower Risk for Necrotizing Enterocolitis in Neonates with Complex Congenital Heart Disease.

Authors:  Acacia Cognata; Jasmeet Kataria-Hale; Pamela Griffiths; Shiraz Maskatia; Danielle Rios; Andrea O'Donnell; Dantin J Roddy; Amy Mehollin-Ray; Joseph Hagan; Jennifer Placencia; Amy B Hair
Journal:  J Pediatr       Date:  2019-09-24       Impact factor: 4.406

2.  Preoperative Feeding Neonates With Cardiac Disease.

Authors:  Carly J Scahill; Eric M Graham; Andrew M Atz; Scott M Bradley; Minoo N Kavarana; Sinai C Zyblewski
Journal:  World J Pediatr Congenit Heart Surg       Date:  2017-01

Review 3.  Nutritional support for children during critical illness: European Society of Pediatric and Neonatal Intensive Care (ESPNIC) metabolism, endocrine and nutrition section position statement and clinical recommendations.

Authors:  Lyvonne N Tume; Frederic V Valla; Koen Joosten; Corinne Jotterand Chaparro; Lynne Latten; Luise V Marino; Isobel Macleod; Clémence Moullet; Nazima Pathan; Shancy Rooze; Joost van Rosmalen; Sascha C A T Verbruggen
Journal:  Intensive Care Med       Date:  2020-02-20       Impact factor: 17.440

Review 4.  Optimal Nutrition Parameters for Neonates and Infants with Congenital Heart Disease.

Authors:  Alina-Costina Luca; Ingrith Crenguța Miron; Dana Elena Mîndru; Alexandrina Ștefania Curpăn; Ramona Cătălina Stan; Elena Țarcă; Florin-Alexandru Luca; Alexandra Ioana Pădureț
Journal:  Nutrients       Date:  2022-04-17       Impact factor: 6.706

Review 5.  Necrotizing Enterocolitis in Children with Congenital Heart Disease: A Literature Review.

Authors:  Sean T Kelleher; Colin J McMahon; Adam James
Journal:  Pediatr Cardiol       Date:  2021-09-12       Impact factor: 1.655

6.  Development of necrotizing enterocolitis in full-term infants with duct dependent congenital heart disease.

Authors:  Gwang-Jun Choi; Jinyoung Song; Hanna Kim; June Huh; I-Seok Kang; Yun Sil Chang; Se In Sung; Myung Chul Hyun
Journal:  BMC Pediatr       Date:  2022-04-02       Impact factor: 2.125

Review 7.  Necrotizing enterocolitis and congenital heart disease.

Authors:  Hadi Kashif; Eyad Abuelgasim; Nafisa Hussain; Jessica Luyt; Amer Harky
Journal:  Ann Pediatr Cardiol       Date:  2022-03-25

8.  Evaluating the Impact of a Feeding Protocol in Neonates before and after Biventricular Cardiac Surgery.

Authors:  Jamie Furlong-Dillard; Alaina Neary; Jennifer Marietta; Courtney Jones; Grace Jeffers; Lindsey Gakenheimer; Michael Puchalski; Aaron Eckauser; Claudia Delgado-Corcoran
Journal:  Pediatr Qual Saf       Date:  2018-05-18

Review 9.  Enteral Nutrition in Term Infants with Congenital Heart Disease: Knowledge Gaps and Future Directions to Improve Clinical Practice.

Authors:  Silvia Martini; Isadora Beghetti; Mariarosaria Annunziata; Arianna Aceti; Silvia Galletti; Luca Ragni; Andrea Donti; Luigi Corvaglia
Journal:  Nutrients       Date:  2021-03-13       Impact factor: 5.717

10.  A role for abdominal ultrasound in discriminating suspected necrotizing enterocolitis in congenital heart disease patients.

Authors:  Stefanie P Lazow; Sarah A Tracy; Judy A Estroff; Richard B Parad; Ilse M Castro-Aragon; Alan M Fujii; Steven J Staffa; David Zurakowski; Catherine Chen
Journal:  Pediatr Surg Int       Date:  2021-09-28       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.